J&J Unit To Shell Out $85M Over Bad Natrecor Labeling

Law360, New York (September 14, 2011, 7:39 PM EDT) -- Johnson & Johnson subsidiary Scios Inc. agreed Wednesday to pay $85 million to settle criminal charges in California that it failed to provide adequate usage directions for heart failure drug Natrecor.

Scios will plead guilty to violating the Food and Drug Administration Act and will be put on organizational probation for three years, according to the plea agreement.

"It is an appropriate penalty given the income, financial resources and earning capacity of Scios and its parent company, Johnson & Johnson; the limited burden such fine places...
To view the full article, register now.